p53-independent ibrutinib responses in an Eμ-TCL1 mouse model demonstrates efficacy in high-risk CLL.
about
p53-independent ibrutinib responses in an Eμ-TCL1 mouse model demonstrates efficacy in high-risk CLL.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
p53-independent ibrutinib resp ...... tes efficacy in high-risk CLL.
@en
p53-independent ibrutinib resp ...... tes efficacy in high-risk CLL.
@nl
type
label
p53-independent ibrutinib resp ...... tes efficacy in high-risk CLL.
@en
p53-independent ibrutinib resp ...... tes efficacy in high-risk CLL.
@nl
prefLabel
p53-independent ibrutinib resp ...... tes efficacy in high-risk CLL.
@en
p53-independent ibrutinib resp ...... tes efficacy in high-risk CLL.
@nl
P2093
P2860
P50
P356
P1433
P1476
p53-independent ibrutinib resp ...... tes efficacy in high-risk CLL.
@en
P2093
A Quintas-Cardama
L R Pageon
P2860
P2888
P356
10.1038/BCJ.2016.41
P577
2016-06-10T00:00:00Z
P6179
1010584562